title: Gene transfer in inner ear cells: a challenging race.
abstract: Recent advances in human genomics led to the identification of numerous defective genes causing deafness, which represent novel putative therapeutic targets. Future gene-based treatment of deafness resulting from genetic or acquired sensorineural hearing loss may include strategies ranging from gene therapy to antisense delivery. For successful development of gene therapies, a minimal requirement involves the engineering of appropriate gene carrier systems. Transfer of exogenous genetic material into the mammalian inner ear using viral or non-viral vectors has been characterized over the last decade. The nature of inner ear cells targeted, as well as the transgene expression level and duration, are highly dependent on the vector type, the route of administration and the strength of the promoter driving expression. This review summarizes and discusses recent advances in inner ear gene-transfer technologies aimed at examining gene function or identifying new treatment for inner ear disorders.
authors: GIGA-Neurosciences, Developmental Neurobiology Unit, University of Liège, Liège, Belgium.
authors: R
authors: R
authors: Sacheli
authors: L
authors: L
authors: Delacroix
authors: P
authors: P
authors: Vandenackerveken
authors: L
authors: L
authors: Nguyen
authors: B
authors: B
authors: Malgrange
mesh_terms: D007758:Ear, Inner / Q000166:cytology / Q000378:metabolism*; D015870:Gene Expression; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods* / Q000639:trends; D005822:Genetic Vectors / Q000235:genetics; D006198:Hair Cells, Auditory / Q000378:metabolism; D006801:Humans; D007759:Labyrinth Diseases / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D019076:Transgenes / Q000235:genetics